Lanean...

Everolimus in Postmenopausal, Hormone Receptor-Positive Advanced Breast Cancer: Summary and Results of an Austrian Expert Panel Discussion

In patients with hormone receptor-positive advanced breast cancer, response to endocrine therapy is frequently limited by endocrine resistance. One important mechanism of resistance is related to mammalian target of rapamycin (mTOR), a molecule involved in the activation of alternative signaling pat...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Gnant, Michael, Greil, Richard, Hubalek, Michael, Steger, Günther
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: S. Karger GmbH 2013
Gaiak:
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3808223/
https://ncbi.nlm.nih.gov/pubmed/24415983
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000354121
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!